Jack Nathan Medical Corp.
JNHMF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Market Cap | $10 | $4 | $6 | $17 |
| - Cash | $2 | $3 | $1 | $1 |
| + Debt | $0 | $12 | $5 | $1 |
| Enterprise Value | $9 | $13 | $9 | $17 |
| Revenue | $9 | $19 | $15 | $10 |
| % Growth | -54.5% | 23.6% | 60.7% | – |
| Gross Profit | $7 | $14 | $12 | $7 |
| % Margin | 84.7% | 75.6% | 76.3% | 71.8% |
| EBITDA | -$2 | -$4 | -$4 | -$6 |
| % Margin | -17.7% | -22.5% | -28.5% | -63.3% |
| Net Income | $7 | -$7 | -$7 | -$8 |
| % Margin | 85.7% | -34.7% | -45.7% | -81% |
| EPS Diluted | -0.03 | -0.078 | -0.084 | -0.095 |
| % Growth | 61.3% | 7.6% | 11.5% | – |
| Operating Cash Flow | -$6 | -$6 | -$2 | -$4 |
| Capital Expenditures | -$1 | -$4 | -$3 | -$1 |
| Free Cash Flow | -$8 | -$10 | -$5 | -$5 |